BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2148146)

  • 41. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism.
    Vähäpassi J; Pyörälä T
    Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
    Nikschick S; Göretzlehner G; Männchen E; Brachmann K
    Exp Clin Endocrinol; 1985 Jun; 85(3):257-62. PubMed ID: 3899684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An investigation on the influence of steroidal contraceptives on milk lipid and fatty acids in Hungary and Thailand. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on oral contraceptives.
    Sas M; Gellen JJ; Dusitsin N; Tunkeyoon M; Chalapati S; Crawford MA; Drury PJ; Lenihan T; Ayeni O; Pinol A
    Contraception; 1986 Feb; 33(2):159-78. PubMed ID: 2938886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Incidence of side effects of a 3-stage preparation administered to 10,034 women].
    Cirkel U; Schneider HP
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):969-73. PubMed ID: 2086337
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current status of oral contraceptive.
    Ping WW; Puvan IS
    Med J Malaysia; 1976 Mar; 30(3):173-7. PubMed ID: 822261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral contraception: a review.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():16-25. PubMed ID: 1687400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
    Amatayakul K; Sivassomboon B; Singkamani R
    Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contraceptive options for the gestational diabetic woman.
    Shoupe D; Bopp B
    Int J Fertil; 1991; 36 Suppl 2():80-4; discussion 84-6. PubMed ID: 1679421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of injectable and oral contraceptives on glucose and insulin levels.
    Berenson AB; van den Berg P; Williams KJ; Rahman M
    Obstet Gynecol; 2011 Jan; 117(1):41-47. PubMed ID: 21173642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced anaerobic glycolysis in oral contraceptive users.
    Vijayalakshmi R; Bamji MS; Ramalakshmi BA
    Contraception; 1988 Jul; 38(1):91-7. PubMed ID: 2971503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
    Mohebbi-Kian E; Mohammad-Alizadeh-Charandabi S; Bekhradi R
    Contraception; 2014 Oct; 90(4):440-6. PubMed ID: 24981150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.
    Geil RG; Lamar JK
    J Toxicol Environ Health; 1977 Sep; 3(1-2):179-93. PubMed ID: 411941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of low-dose estrogen and progestogen on menopausal symptoms and urinary excretion of calcium.
    Lin SQ; Ge QS; Yao FY; Feng DD; Wang HL
    Chin Med J (Engl); 1990 Aug; 103(8):652-7. PubMed ID: 2147000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral contraception enhances growth hormone responsiveness to hyper- and hypoglycaemia.
    Friedrich A; Ludwig AK; Jauch-Chara K; Loebig M; Rudolf S; Tauchert S; Diedrich K; Schweiger U; Oltmanns KM
    Diabet Med; 2012 Mar; 29(3):345-50. PubMed ID: 21883439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial carcinoma and oral contraceptive agents.
    Cohen CJ; Deppe G
    Obstet Gynecol; 1977 Apr; 49(4):390-2. PubMed ID: 193073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
    Hirvonen E; Lipasti A; Mälkönen M; Kärkkäinen J; Nuntila J; Timonen H; Manninen V
    Maturitas; 1987 Apr; 9(1):69-79. PubMed ID: 2955205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effects of Depo-Provera on carbohydrate and lipid metabolism.
    Liew DF; Ng CS; Yong YM; Ratnam SS
    Contraception; 1985 Jan; 31(1):51-64. PubMed ID: 3157546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Program of surveillance of patients under oral contraceptives].
    Lefebvre Y
    Union Med Can; 1975 Oct; 104(10):1535-9. PubMed ID: 1220102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated prolactin levels in oral contraceptive pill-related hypertension.
    Lehtovirta P; Ranta T; Seppälä M
    Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.